What is the current stock price of GSK plc (GSK)?

As of the latest market data, GSK plc (GSK) is trading at $58.21. The stock has seen a loss of -0.26% today.

Does GSK plc (GSK) pay a dividend?

Based on current data, GSK plc does not have a confirmed active dividend policy.

What is the market cap of GSK plc?

The current market capitalization of GSK plc (GSK) is approximately unavailable.

GSK

GSK plc·Healthcare

58.21

0.257%(−0.15)

Market Closed

58.55

0.584%(+0.34)

After Hours

Last Updated: — ET

52W L: $34.7352W H: $61.70

GSK NEWS

zacks.com

17h ago

Why GSK (GSK) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

defenseworld.net

1d ago

Douglas Lane & Associates LLC Cuts Holdings in GSK PLC Sponsored ADR $GSK

Douglas Lane and Associates LLC reduced its position in GSK PLC Sponsored ADR (NYSE: GSK) by 6.8% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,044,790 shares of the pharmaceutical company's stock after selling 76,109 shares during the quarter. Douglas Lane and

wsj.com

1d ago

GSK withdrew an application of a drug touted by Trump and RFK Jr. as a potential treatment for autism. The drug's label last month was updated so that generic versions of it can be marketed for a rare genetic, neurological condition, but not autism.

Generic versions of the drug will still be available to treat a rare genetic condition.

zacks.com

3d ago

GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

prnewswire.com

Mar 31

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishes its first U.S. manufacturing presence, expanding regional client support Plans further investments to add capabilities and strengthen long-term operations at the Rockville site INCHEON, South Korea and ROCKVILLE, MD., March 31, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company's first manufacturing presence in the United States.

seekingalpha.com

Mar 26

GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript

Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

68,629

IPO Date

1980-03-28

Beta

0.35

Websitewww.gsk.com↗